From: The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial
Treatment group
GOS
Good (GOS 4 to 5)
Poor (GOS 1 to 3)
Placebo
5
1
IL-1Ra
Total
10
2